Patriot Financial Group Insurance Agency’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.55M | Sell |
29,644
-22,712
| -43% | -$1.2M | 0.16% | 161 |
|
|
2026
Q1 | $2.89M | Buy |
52,356
+28,315
| +118% | +$1.53M | 0.16% | 158 |
|
|
2025
Q4 | $1.18M | Buy |
24,041
+335
| +1% | +$15.6K | 0.14% | 184 |
|
|
2025
Q3 | $1.02M | Buy |
23,706
+2,068
| +10% | +$80.8K | 0.13% | 193 |
|
|
2025
Q2 | $831K | Buy |
21,638
+1,438
| +7% | +$54.9K | 0.1% | 235 |
|
|
2025
Q1 | $783K | Buy |
20,200
+2,290
| +13% | +$83.8K | 0.1% | 221 |
|
|
2024
Q4 | $606K | Buy |
17,910
+1,502
| +9% | +$54.1K | 0.08% | 256 |
|
|
2024
Q3 | $671K | Buy |
16,408
+903
| +6% | +$36.9K | 0.09% | 239 |
|
|
2024
Q2 | $597K | Buy |
15,505
+155
| +1% | +$6.52K | 0.09% | 246 |
|
|
2024
Q1 | $658K | Buy |
15,350
+845
| +6% | +$34.8K | 0.1% | 217 |
|
|
2023
Q4 | $538K | Buy |
14,505
+7
| +0% | +$251 | 0.1% | 236 |
|
|
2023
Q3 | $526K | Buy |
+14,498
| New | +$515K | 0.11% | 224 |
|
|
2022
Q3 | – | Sell |
-1,198
| Closed | -$65K | – | 1027 |
|
|
2022
Q2 | $65K | Sell |
1,198
-354
| -23% | -$19.5K | 0.01% | 652 |
|
|
2022
Q1 | $85K | Sell |
1,552
-919
| -37% | -$49.9K | 0.02% | 626 |
|
|
2021
Q4 | $136K | Buy |
2,471
+598
| +32% | +$31.1K | 0.02% | 556 |
|
|
2021
Q3 | $89K | Buy |
1,873
+996
| +114% | +$50K | 0.02% | 690 |
|
|
2021
Q2 | $44K | Buy |
877
+126
| +17% | +$6.05K | 0.01% | 880 |
|
|
2021
Q1 | $34K | Sell |
751
-574
| -43% | -$26.1K | 0.01% | 902 |
|
|
2020
Q4 | $61K | Sell |
1,325
-9,403
| -88% | -$432K | 0.02% | 628 |
|
|
2020
Q3 | $504K | Sell |
10,728
-5,199
| -33% | -$260K | 0.16% | 129 |
|
|
2020
Q2 | $812K | Buy |
15,927
+14,607
| +1,107% | +$749K | 0.31% | 73 |
|
|
2020
Q1 | $63K | Buy |
1,320
+608
| +85% | +$32.4K | 0.03% | 407 |
|
|
2019
Q4 | $42K | Sell |
712
-130
| -15% | -$7.23K | 0.02% | 508 |
|
|
2019
Q3 | $45K | Buy |
842
+80
| +10% | +$4.12K | 0.02% | 459 |
|
|
2019
Q2 | $39K | Sell |
762
-912
| -54% | -$45.8K | 0.02% | 478 |
|
|
2019
Q1 | $87K | Hold |
1,674
| – | – | 0.04% | 293 |
|
|
2018
Q4 | $80K | Buy |
1,674
+66
| +4% | +$3.25K | 0.05% | 243 |
|
|
2018
Q3 | $81K | Buy |
1,608
+1,189
| +284% | +$60.4K | 0.05% | 229 |
|
|
2018
Q2 | $21K | Sell |
419
-671
| -62% | -$33.8K | 0.02% | 284 |
|
|
2018
Q1 | $53K | Sell |
1,090
-116
| -10% | -$5.4K | 0.04% | 302 |
|
|
2017
Q4 | $57K | Sell |
1,206
-406
| -25% | -$18.8K | 0.04% | 276 |
|
|
2017
Q3 | $82K | Sell |
1,612
-41
| -2% | -$2.08K | 0.07% | 197 |
|
|
2017
Q2 | $87K | Buy |
1,653
+143
| +9% | +$7.62K | 0.09% | 175 |
|
|
2017
Q1 | $79K | Hold |
1,510
| – | – | 0.08% | 172 |
|
|
2016
Q4 | $73K | Buy |
+1,510
| New | +$74.6K | 0.1% | 176 |
|
Other funds holding GSK
JEST
Patriot Financial Group Insurance Agency's GSK Position: Q2 2026 in Review
Patriot Financial Group Insurance Agency reduced its GSK (GSK) stake by 43% in Q2 2026, selling an estimated $1.2M and leaving 29,644 shares worth $1.55M. The position accounts for 0.16% of the portfolio, ranked #161.
Patriot Financial Group Insurance Agency first reported a position in GSK in Q4 2016 and has held it in 35 quarters since. The position peaked at $2.89M in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Patriot Financial Group Insurance Agency held 29,644 shares of GSK worth $1.55M as of Q2 2026.
- Patriot Financial Group Insurance Agency sold 22,712 GSK shares in Q2 2026, an estimated $1.2M.
- GSK made up 0.16% of Patriot Financial Group Insurance Agency's portfolio in Q2 2026, its #161 holding.
- Patriot Financial Group Insurance Agency first reported a position in GSK in Q4 2016 and has held it in 35 quarters since.
- Patriot Financial Group Insurance Agency's GSK position peaked at $2.89M in Q1 2026.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Patriot Financial Group Insurance Agency's 13F filing for Q2 2026, filed 16 Jul 2026.